New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 1.890
0.00 (0.00%)
Oct 30, 2026, 3:04 PM CST
SHE:002219 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 6,505 | 7,194 | 8,916 | 10,335 | 12,861 | 6,827 | |
Market Cap Growth | -15.15% | -19.32% | -13.72% | -19.64% | 88.39% | 106.78% |
Enterprise Value | 8,168 | 8,441 | 10,339 | 11,320 | 12,997 | 8,228 |
Last Close Price | 1.89 | 2.13 | 2.64 | 3.03 | 3.94 | 3.66 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 94.81 | 232.49 | 77.69 | 356.71 | 82.38 | - |
Forward PE | - | 59.75 | 59.75 | 59.75 | 59.75 | 59.75 |
PS Ratio | 2.24 | 2.36 | 2.35 | 2.64 | 4.07 | 2.26 |
PB Ratio | 3.20 | 3.58 | 4.37 | 4.76 | 7.28 | 4.30 |
P/TBV Ratio | 13.76 | 16.24 | 19.18 | 17.58 | 22.43 | 17.17 |
P/FCF Ratio | - | 195.58 | 68.03 | 92.90 | 276.78 | 86.89 |
P/OCF Ratio | 34.82 | 24.49 | 20.33 | 32.20 | 47.98 | 24.62 |
PEG Ratio | - | 3.52 | 3.52 | 3.52 | 3.52 | 3.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 2.81 | 2.77 | 2.72 | 2.89 | 4.11 | 2.73 |
EV/EBITDA Ratio | 17.44 | 23.64 | 21.52 | 29.43 | 33.68 | 64.65 |
EV/EBIT Ratio | 27.98 | 41.22 | 33.65 | 64.00 | 56.53 | - |
EV/FCF Ratio | - | 229.49 | 78.88 | 101.75 | 279.72 | 104.73 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.92 | 0.95 | 0.97 | 1.11 | 0.73 | 1.23 |
Debt / EBITDA Ratio | 4.00 | 4.86 | 3.77 | 5.79 | 3.25 | 15.29 |
Debt / FCF Ratio | - | 51.78 | 15.04 | 21.61 | 27.72 | 24.86 |
Net Debt / Equity Ratio | 0.79 | 0.75 | 0.73 | 0.83 | 0.41 | -0.05 |
Net Debt / EBITDA Ratio | 3.74 | 4.22 | 3.11 | 4.69 | 1.89 | -0.63 |
Net Debt / FCF Ratio | -111.77 | 41.01 | 11.39 | 16.20 | 15.68 | -1.02 |
Asset Turnover | 0.44 | 0.46 | 0.57 | 0.64 | 0.51 | 0.52 |
Inventory Turnover | 10.63 | 12.31 | 12.20 | 13.92 | 12.34 | 12.15 |
Quick Ratio | 0.47 | 0.49 | 0.50 | 0.52 | 0.44 | 0.60 |
Current Ratio | 0.54 | 0.54 | 0.57 | 0.59 | 0.54 | 0.66 |
Return on Equity (ROE) | 3.61% | 1.65% | 5.71% | 2.02% | 9.84% | -42.13% |
Return on Assets (ROA) | 2.77% | 1.92% | 2.89% | 1.80% | 2.33% | -0.39% |
Return on Invested Capital (ROIC) | 4.26% | 2.49% | 6.39% | 5.47% | 10.11% | -2.17% |
Return on Capital Employed (ROCE) | 9.30% | 6.60% | 9.80% | 5.60% | 9.90% | -1.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.05% | 0.43% | 1.29% | 0.28% | 1.21% | -5.44% |
FCF Yield | -0.22% | 0.51% | 1.47% | 1.08% | 0.36% | 1.15% |
Payout Ratio | - | 325.46% | 103.03% | 366.45% | 176.67% | - |
Buyback Yield / Dilution | -6.39% | -0.10% | -1.02% | 0.33% | -75.08% | 0.02% |